Skip to main content
Top
Published in: World Journal of Urology 3/2016

01-03-2016 | Original Article

Predictors of de novo urge urinary incontinence after photoselective vaporization of the prostate

Authors: Jungbum Bae, Hyoun Woo Kang, Hae Won Lee, Kwang Soo Lee, Min Chul Cho

Published in: World Journal of Urology | Issue 3/2016

Login to get access

Abstract

Purpose

To investigate serial changes in the incidences of de novo urge urinary incontinence (UUI) after photoselective vaporization of the prostate (PVP) for BPH using a validated questionnaire, OABSS, and to determine predictors of postoperative de novo UUI (dnUUI).

Methods

A total of 84 men, for whom 12-month follow-up data were available and who did not complain of UUI based on the OABSS [score of OABSS question 4 (OABSS4) ≤1], were included in this study. Outcomes were evaluated at 1 week, and 1, 3, 6, and 12 months postoperatively using IPSS, OABSS, and uroflowmetry. The presence of de novo UUI was defined as OABSS4 ≥2 at the follow-up visit.

Results

Maximum flow rate (Qmax), post-void residual urine volume, voiding symptom score, total IPSS, and QOL index improved from 1 week. Storage symptom score and total OABSS improved from 3 months. Incidences of postoperative dnUUI at 1 week, and 1, 3, and 6 months were 42.9, 27.4, 14.3, and 0.0 %, respectively. The decrease in QOL index in patients with dnUUI at each follow-up visit was lesser than in those without dnUUI. On multivariate regression analysis, older age, shorter time to Qmax on baseline uroflowmetry, higher storage symptom score, higher total OABSS, smaller bladder volume at first desire to void, and smaller maximum cystometric capacity (MCC) on baseline urodynamics were independent predictors of occurrence of dnUUI.

Conclusions

Our data indicate that transient dnUUI occurs in a significant proportion of patients after PVP and it tends to decrease over time. Older-aged patients, patients with shorter time to Qmax, higher baseline storage symptom score, higher baseline total OABSS, smaller bladder volume at first desire to void, and smaller MCC may be prone to develop dnUUI postoperatively.
Literature
1.
go back to reference Han E, Black LK, Lavelle JP (2007) Incontinence related to management of benign prostatic hypertrophy. Am J Geriatr Pharmacother 5:324–334CrossRefPubMed Han E, Black LK, Lavelle JP (2007) Incontinence related to management of benign prostatic hypertrophy. Am J Geriatr Pharmacother 5:324–334CrossRefPubMed
2.
go back to reference Bruschini H, Simonetti R, Antunes AA, Srougi M (2011) Urinary incontinence following surgery for BPH: the role of aging on the incidence of bladder dysfunction. Int Braz J Urol 37:380–387CrossRefPubMed Bruschini H, Simonetti R, Antunes AA, Srougi M (2011) Urinary incontinence following surgery for BPH: the role of aging on the incidence of bladder dysfunction. Int Braz J Urol 37:380–387CrossRefPubMed
3.
go back to reference Rassweiler J, Tebera D, Kuntz R et al (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50:969–979CrossRefPubMed Rassweiler J, Tebera D, Kuntz R et al (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50:969–979CrossRefPubMed
4.
go back to reference Chughtai B, Te A (2011) Photoselective vaporization of the prostate for treating benign prostatic hyperplasia. Expert Rev Med Devices 8:591–595CrossRefPubMed Chughtai B, Te A (2011) Photoselective vaporization of the prostate for treating benign prostatic hyperplasia. Expert Rev Med Devices 8:591–595CrossRefPubMed
5.
go back to reference Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH (2007) Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 100:593–598CrossRefPubMed Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH (2007) Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int 100:593–598CrossRefPubMed
6.
go back to reference Pereira-Correia JA, de Moraes Sousa KD, Santos JB et al (2012) GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 110:1184–1189CrossRefPubMed Pereira-Correia JA, de Moraes Sousa KD, Santos JB et al (2012) GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation. BJU Int 110:1184–1189CrossRefPubMed
7.
go back to reference Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97:1229–1233CrossRefPubMed Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97:1229–1233CrossRefPubMed
8.
go back to reference Jeong SJ, Homma Y, Oh SJ (2011) Korean version of the overactive bladder symptom score questionnaire: translation and linguistic validation. Int Neurourol J 15:135–142PubMedCentralCrossRefPubMed Jeong SJ, Homma Y, Oh SJ (2011) Korean version of the overactive bladder symptom score questionnaire: translation and linguistic validation. Int Neurourol J 15:135–142PubMedCentralCrossRefPubMed
9.
go back to reference Jeong SJ, Homma Y, Oh SJ (2014) Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms. Qual Life Res 23:285–292CrossRefPubMed Jeong SJ, Homma Y, Oh SJ (2014) Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms. Qual Life Res 23:285–292CrossRefPubMed
10.
go back to reference Malek RS, Kuntzman RS, Barrett DM (2000) High power potassium–titanyl-phosphate laser vaporization prostatectomy. J Urol 163:1730–1733CrossRefPubMed Malek RS, Kuntzman RS, Barrett DM (2000) High power potassium–titanyl-phosphate laser vaporization prostatectomy. J Urol 163:1730–1733CrossRefPubMed
11.
go back to reference Van Kampen M, De Weerdt W, Van Poppel H, Baert L (1997) Urinary incontinence following transurethral, transvesical and radical prostatectomy. Retrospective study of 489 patients. Acta Urol Belg 65:1–7PubMed Van Kampen M, De Weerdt W, Van Poppel H, Baert L (1997) Urinary incontinence following transurethral, transvesical and radical prostatectomy. Retrospective study of 489 patients. Acta Urol Belg 65:1–7PubMed
12.
go back to reference Chang PL, Tsai LH, Huang ST, Wang TM, Hsieh ML, Tsui KH (1998) The early effect of pelvic floor muscle exercise after transurethral prostatectomy. J Urol 160:402–405CrossRefPubMed Chang PL, Tsai LH, Huang ST, Wang TM, Hsieh ML, Tsui KH (1998) The early effect of pelvic floor muscle exercise after transurethral prostatectomy. J Urol 160:402–405CrossRefPubMed
13.
go back to reference Latini JM, Giannantoni A (2011) Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder. Expert Opin Pharmacother 12:1017–1027CrossRefPubMed Latini JM, Giannantoni A (2011) Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder. Expert Opin Pharmacother 12:1017–1027CrossRefPubMed
14.
go back to reference Porru D, Campus G, Caria A, Madeddu G, Cucchi A, Rovereto B, Scarpa RM, Pili P, Usai E (2001) Impact of early pelvic floor rehabilitation after transurethral resection of the prostate. Neurourol Urodyn 20:53–59CrossRefPubMed Porru D, Campus G, Caria A, Madeddu G, Cucchi A, Rovereto B, Scarpa RM, Pili P, Usai E (2001) Impact of early pelvic floor rehabilitation after transurethral resection of the prostate. Neurourol Urodyn 20:53–59CrossRefPubMed
15.
go back to reference Hou CP, Chen TY, Chang CC, Lin YH, Chang PL, Chen CL, Hsu YC, Tsui KH (2013) Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery. Clin Interv Aging 8:667–673PubMedCentralPubMed Hou CP, Chen TY, Chang CC, Lin YH, Chang PL, Chen CL, Hsu YC, Tsui KH (2013) Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery. Clin Interv Aging 8:667–673PubMedCentralPubMed
16.
go back to reference Mitropoulos D, Papadoukakis S, Zervas A, Alamanis C, Giannopoulos A (2006) Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy. Int Urol Nephrol 38:263–268CrossRefPubMed Mitropoulos D, Papadoukakis S, Zervas A, Alamanis C, Giannopoulos A (2006) Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy. Int Urol Nephrol 38:263–268CrossRefPubMed
Metadata
Title
Predictors of de novo urge urinary incontinence after photoselective vaporization of the prostate
Authors
Jungbum Bae
Hyoun Woo Kang
Hae Won Lee
Kwang Soo Lee
Min Chul Cho
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 3/2016
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-015-1635-z

Other articles of this Issue 3/2016

World Journal of Urology 3/2016 Go to the issue